Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00647959 | Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg | PHASE1 | COMPLETED | 36 | — | — | Mar 1, 2006 | Apr 1, 2006 | Apr 24, 2024 | 1 | United States |
| NCT00648180 | Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg | PHASE1 | COMPLETED | 36 | — | — | Jul 1, 2005 | Aug 1, 2005 | Apr 24, 2024 | 1 | United States |
| NCT00649571 | Fasting Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg | PHASE1 | COMPLETED | 35 | — | — | Jul 1, 2005 | Jul 1, 2005 | Apr 24, 2024 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Doxycycline Tablets, 150mg |
| 2 | ACTIVE_COMPARATOR | Adoxa Tablets 150 mg |
| Name | Type | Description |
|---|---|---|
| Doxycycline Tablets, 150mg | DRUG | 150mg, single dose fasting |
| Adoxa Tablets 150 mg | DRUG | 150mg, single dose fasting |
| Doxycycline Monohydrate Tablets 100 mg | DRUG | 100mg, single dose fed |
| Adoxa Tablets 100 mg | DRUG | 100mg, single dose fed |
| Doxycycline Monohydrate Tablets (100 mg | DRUG | 100mg, single dose fasting |
Inclusion Criteria: 1. Age: 18 years and older. 2. Sex: Male and/or non-pregnant, non-lactating female. 1. Women of childbearing potential must have negative serum beta human chorionic gonadotropin (beta-HCG) pregnancy tests performed within 21 days prior to the start of the study and on the ev...